Principle Investigator:
Dr. Cameron Mitchell
Details:
It is estimated that 70% of individuals who undergo a massive weight loss develop excess skin (ES). The ES around the abdominal area has been shown through patient reported outcome measures (PROs) to negatively impact physical function. Yet no studies have examined the impact of surgeries that remove ES on direct measures of physical function of those who had a massive weight loss. Therefore, the purpose of the current study is to examine the impact of abdominal excess skin removal surgeries on direct measures of physical function in individuals who have undergone a massive weight loss.
What is involved?
As a participant in this study, you would be asked to participate in a measure of body composition, completing questionnaires and simple physical function tests assessing your walks, balance and strength. Your participation would involve 2 sessions separated by 8-12 weeks, each of which is approximately 110 minutes.
Eligibility Criteria:
Those who might be considered for participation in the study would include those who
□ Are an abled body and can perform day to day tasks
□ Have lost a minimum of 25% of their original weight
□ Have Body Mass Index (BMI) between 25-40 kg/m2
□ Are between age 18-65 years-old
□ Have excess skin in the abdominal area
□ Are weight stable with no more than 5% weight change in the past 3 months
□ Are not on atypical antipsychotics including but not limited to clozapine, olanzapine, quetiapine, risperidone, aripiprazole, amisulpiride, ziprasidone, asenapine, iloperidone, lurasidone and paliperidone.
□ Are non-smokers
What do we offer?
In appreciation for your time, you will receive financial compensation, in addition to a free-of- charge fitness report card indicating your body composition and exercise capacity. Physical activity advice will also be provided to you by an exercise professional.
How do I participate?
Contact: Sobhan Mardan-Dezfouli by email: smardand@alumni.ubc.ca or call 778-320-0253.
Thank you,
Poster:
End date:
08/20/2021